Home › Dementia › Texas › Houston
Dementia clinical trials in Houston, TX
5 studies for Dementia are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RecruitingPhase 4Healthy volunteers welcome
- University of Texas at Houston, Houston
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
RecruitingPhase 1/2
- Houston Methodist Hospital, Houston
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
RecruitingPhase 3
- The University of Texas Health Science Center at Houston, Houston
Open-label Extension Study in Participants With Early Alzheimer's Disease
RecruitingPhase 2
- GSK Investigational Site, Houston
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
RecruitingObservational studyHealthy volunteers welcome
- University of Texas Health Science Center, Houston
About Dementia
People with dementia have serious problems with two or more brain functions, such as memory and language. Affects the ability to do normal activities.
More about Dementia on MedlinePlus
Dementia trials in other cities
- Los Angeles, CA12 studies
- New York City, NY12 studies
- Chicago, IL10 studies
- Baltimore, MD8 studies
- San Diego, CA8 studies
- Boston, MA8 studies
- St. Louis, MO8 studies
- Durham, NC8 studies
- Orlando, FL8 studies
- Tampa, FL8 studies
- Atlanta, GA8 studies
- Indianapolis, IN8 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.